As of March 2025 Nektar Therapeutics has a market cap of โฌ0.13 Billion. This makes Nektar Therapeutics the world's 8584th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โฌ0.13 B | -17.58% |
2024 | โฌ0.16 B | 72.56% |
2023 | โฌ97.5 M | -75.38% |
2022 | โฌ0.39 B | -82.01% |
2021 | โฌ2.20 B | -11.21% |
2020 | โฌ2.47 B | -27.09% |
2019 | โฌ3.40 B | -31.79% |
2018 | โฌ4.98 B | -36.38% |
2017 | โฌ7.83 B | 339.61% |
2016 | โฌ1.78 B | -14.49% |
2015 | โฌ2.08 B | 24.67% |
2014 | โฌ1.67 B | 74.67% |
2013 | โฌ0.95 B | 48.28% |
2012 | โฌ0.64 B | 30.97% |
2011 | โฌ0.49 B | -46.01% |
2010 | โฌ0.91 B | 50.48% |
2009 | โฌ0.60 B | 65.04% |
2008 | โฌ0.36 B | -13.32% |
2007 | โฌ0.42 B | -59.69% |
2006 | โฌ1.05 B | -13.66% |
2005 | โฌ1.21 B | -3.42% |
2004 | โฌ1.26 B | 107.72% |
2003 | โฌ0.60 B | 41.48% |
2002 | โฌ0.42 B | -62.89% |
2001 | โฌ1.15 B | -54.43% |
2000 | โฌ2.53 B | 248.53% |
1999 | โฌ0.72 B | 54.82% |
1998 | โฌ0.47 B | 38.21% |
1997 | โฌ0.34 B | 125.73% |
1996 | โฌ0.15 B |
On Mar 25th, 2025 the market cap of Nektar Therapeutics was reported to be: